Eli Lilly Raises 2026 Forecast After Strong Half-Year Results

Pharmaceutical giant Eli Lilly significantly beat expectations with its first-half 2026 results, leading the company to raise its full-year revenue forecast to $85-87 billion.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

berlingskeDanish2h ago

Novo-konkurrents omsætning banker op – slår forventninger markant og opjusterer

Mens medicinalkæmpen Novo Nordisk præsenterede sine halvårsresultater tirsdag aften, har den amerikanske storkonkurrent Eli Lilly netop fremlagt sine tal for første halvår af2026.

Read full article →

PERSPECTA

PERSPECTA

Eli Lilly Raises 2026 Forecast After Strong Half-Year Results

Sources

Novo-konkurrents omsætning banker op – slår forventninger markant og opjusterer

Related Stories

Assuta and Microsoft Develop AI Medical Assistant

Wolt Receives Over 27,000 Courier Applications After Banning Shared Accounts

Telecom Companies to Replace Mobile-ID SIM Cards Due to EU Regulation

Disney+ Temporarily Removes HDR and 4K Streaming Amid Patent Dispute

PERSPECTA